Nifty healthcare index stocks analysts suggest buying have potential upside of more than 19%

Except for a pocket in which demand for covid drugs led to sharp surge in pharma stocks, the pharma sector had been under pressure for a long time..

After a long phase of consolidation, in which some companies have implemented change in their business model, are pharma stocks close to breakout ?.

Stock Reports Plus, powered by Refinitiv, is a comprehensive research report that evaluates five key components of 4,000+ listed stocks - earnings, fundamentals, relative valuation, risk and price momentum to generate standardized scores...

Why it is important to dalal street, a large number of Indian pharma companies have presence in US generic markets and they have been witnessing pricing pressure. But how much can the margin get squeezed, if the recent trends are anything to go by then at the rate at which prices were falling have slowed down..

You might be interested in